Product Information

BUPROPION HCL SR 150 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.2715 per EA under NDC 43598086360. Its NADAC has been published 375 times since Sep 18, 2019.

FDA first approved this application on Aug 17, 2016. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPROPION HCL SR 150 MG TABLET

Bupropion Hydrochloride
$0.2715per EA

Strength

150 mg/1

NDC

43598086360

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA206122

FDA Approved

8/17/2016

TE Code

AB2

On Market Since

8/17/2016

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL SR 150 MG TABLET has been published 375 times since Sep 18, 2019, and over the history we have for it it has declined 23.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2715 per EA
All-time high$0.3996 (Apr 15, 2020)
All-time low$0.1923 (Jul 17, 2024)
52-week high$0.2859
52-week low$0.2443
Median price$0.3051
Average price$0.3040
Largest weekly change+70.2% (Aug 21, 2024)
Weeks tracked375
Tracking sinceSep 18, 2019

Price History

1W

+2.0%

1M

+7.6%

3M

+8.0%

6M

-2.2%

1Y

+10.7%

3Y

-11.0%

5Y

+4.7%

All

-23.5%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 72% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUPROPION HCL SR 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 150 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.2715 per EA (NDC 43598086360), effective Nov 18, 2026.

How has the price of BUPROPION HCL SR 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL SR 150 MG TABLET has declined 23.5%. It has been tracked across 375 weekly CMS publications since Sep 18, 2019.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 150 MG TABLET?

Since Sep 18, 2019, the NADAC for BUPROPION HCL SR 150 MG TABLET has ranged from a low of $0.1923 (Jul 17, 2024) to a high of $0.3996 (Apr 15, 2020), with a median of $0.3051 per EA.

Are there cheaper alternatives to BUPROPION HCL SR 150 MG TABLET?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0747 per EA — about 72% below BUPROPION HCL SR 150 MG TABLET.

Who manufactures BUPROPION HCL SR 150 MG TABLET?

BUPROPION HCL SR 150 MG TABLET (NDC 43598086360) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.